Entity Common Stock, Shares Outstanding of Akebia Therapeutics, Inc. from 30 Apr 2014 to 23 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Akebia Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Apr 2014 to 23 Feb 2026.
  • Akebia Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 23 Feb 2026 was 267,879,239, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Akebia Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 267,879,239 +31,648,182 +13% 23 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 265,365,993 +47,184,791 +22% 04 Nov 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 265,145,038 +54,856,828 +26% 04 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 236,231,057 +26,858,782 +13% 10 Mar 2025 10-K 13 Mar 2025 2024 FY
Q3 2024 218,181,202 +29,867,395 +16% 04 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 210,288,210 05 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 209,372,275 +23,444,154 +13% 13 Mar 2024 10-K 14 Mar 2024 2023 FY
Q3 2023 188,313,807 +4,351,724 +2.4% 25 Aug 2023 10-Q 28 Aug 2023 2023 Q2
Q1 2023 185,928,121 +2,395,046 +1.3% 30 Apr 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 183,962,083 +9,001,670 +5.1% 31 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 183,848,654 +9,311,196 +5.3% 31 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 183,533,075 +23,417,912 +15% 30 Apr 2022 10-Q 09 May 2022 2022 Q1
Q3 2021 174,960,413 +30,421,519 +21% 31 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 174,537,458 +31,220,051 +22% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 160,115,163 +29,849,218 +23% 30 Apr 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 144,538,894 +25,595,878 +22% 30 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 143,317,407 +24,453,672 +21% 31 Jul 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 130,265,945 +13,143,683 +11% 30 Apr 2020 10-Q 05 May 2020 2020 Q1
Q3 2019 118,943,016 +61,883,953 +108% 31 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 118,863,735 +61,818,650 +108% 31 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 117,122,262 +60,239,048 +106% 15 Mar 2019 10-K 26 Mar 2019 2018 FY
Q3 2018 57,059,063 +9,789,910 +21% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 57,045,085 +9,893,656 +21% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 56,883,214 +18,019,976 +46% 30 Apr 2018 10-Q 09 May 2018 2018 Q1
Q3 2017 47,269,153 +8,944,681 +23% 31 Oct 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 47,151,429 +9,139,825 +24% 31 Jul 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 38,863,238 +886,533 +2.3% 30 Apr 2017 10-Q 09 May 2017 2017 Q1
Q3 2016 38,324,472 +7,692,735 +25% 31 Oct 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 38,011,604 +9,129,074 +32% 31 Jul 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 37,976,705 +9,139,445 +32% 30 Apr 2016 10-Q 05 May 2016 2016 Q1
Q3 2015 30,631,737 +10,290,932 +51% 05 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 28,882,530 +8,619,552 +43% 31 Jul 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 28,837,260 +8,574,967 +42% 01 May 2015 10-Q 11 May 2015 2015 Q1
Q3 2014 20,340,805 31 Oct 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 20,262,978 31 Jul 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 20,262,293 30 Apr 2014 10-Q 12 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.